Skip to main content
Top
Published in: Clinical Neuroradiology 3/2014

01-09-2014 | Correspondence

Case Report: Glioblastoma Multiforme Complicating Familial Cavernous Malformations

Authors: D. M. Wilson, MD, PhD, B. Cohen, MD, K. Keshari, PhD, H. Vogel, MD, G. Steinberg, MD, PhD, W. Dillon, MD

Published in: Clinical Neuroradiology | Issue 3/2014

Login to get access

Excerpt

Cerebral cavernous malformations (CCMs) are vascular lesions characterized by enlarged capillary cavities without intervening brain parenchyma, and may be sporadic or familial [2]. Their prevalence is close to 0.5 % in the general population [22]. Familial CCMs are increasingly diagnosed, and newer susceptibility-weighted imaging (SWI) sequences are more sensitive to detection than conventional T2-weighted gradient echo (T2*-GRE) [5]. These lesions have an autosomal dominant inheritance with associated genes mapped to the long and short arms of chromosomes 7, and to the long arm of chromosome 3 [4, 7]. Familial CCMs are multiple, with a 2000 retrospective study in 40 patients from 29 unrelated French families finding that the risk of acute hemorrhage was at least twice as high as that observed in sporadic cases, 13–17 % per patient-year or 2–2.5 % per lesion-year [14]. …
Literature
1.
go back to reference Bergametti F, Denier C, Labauge P, Arnoult M, Boetto S, Clanet M, et al. Mutations within the programmed cell death 10 gene cause cerebral cavernous malformations. Am J Hum Genet. 2005;76:42–51.PubMedCentralPubMedCrossRef Bergametti F, Denier C, Labauge P, Arnoult M, Boetto S, Clanet M, et al. Mutations within the programmed cell death 10 gene cause cerebral cavernous malformations. Am J Hum Genet. 2005;76:42–51.PubMedCentralPubMedCrossRef
2.
go back to reference Cavalcanti DD, Kalani MY, Martirosyan NL, Eales J, Spetzler RF, Preul MC. Cerebral cavernous malformations: from genes to proteins to disease. J Neurosurg. 2012;116:122–32.PubMedCrossRef Cavalcanti DD, Kalani MY, Martirosyan NL, Eales J, Spetzler RF, Preul MC. Cerebral cavernous malformations: from genes to proteins to disease. J Neurosurg. 2012;116:122–32.PubMedCrossRef
3.
go back to reference Chee CP, Johnston R, Doyle D, Macpherson P. Oligodendroglioma and cerebral cavernous angioma. Case report. J Neurosurg. 1985;62:145–7.PubMedCrossRef Chee CP, Johnston R, Doyle D, Macpherson P. Oligodendroglioma and cerebral cavernous angioma. Case report. J Neurosurg. 1985;62:145–7.PubMedCrossRef
4.
go back to reference Craig HD, Gunel M, Cepeda O, Johnson EW, Ptacek L, Steinberg GK, et al. Multilocus linkage identifies two new loci for a mendelian form of stroke, cerebral cavernous malformation, at 7p15–13 and 3q25.2–27. Hum Mol Genet. 1998;7:1851–8.PubMedCrossRef Craig HD, Gunel M, Cepeda O, Johnson EW, Ptacek L, Steinberg GK, et al. Multilocus linkage identifies two new loci for a mendelian form of stroke, cerebral cavernous malformation, at 7p15–13 and 3q25.2–27. Hum Mol Genet. 1998;7:1851–8.PubMedCrossRef
5.
go back to reference de Champfleur NM, Langlois C, Ankenbrandt WJ, Le Bars E, Leroy MA, Duffau H, et al. Magnetic resonance imaging evaluation of cerebral cavernous malformations with susceptibility-weighted imaging. Neurosurgery. 2011;68:641–647; discussion 647–648. de Champfleur NM, Langlois C, Ankenbrandt WJ, Le Bars E, Leroy MA, Duffau H, et al. Magnetic resonance imaging evaluation of cerebral cavernous malformations with susceptibility-weighted imaging. Neurosurgery. 2011;68:641–647; discussion 647–648.
6.
go back to reference Denier C, Goutagny S, Labauge P, Krivosic V, Arnoult M, Cousin A, et al. Mutations within the MGC4607 gene cause cerebral cavernous malformations. Am J Hum Genet. 2004;74:326–37.PubMedCentralPubMedCrossRef Denier C, Goutagny S, Labauge P, Krivosic V, Arnoult M, Cousin A, et al. Mutations within the MGC4607 gene cause cerebral cavernous malformations. Am J Hum Genet. 2004;74:326–37.PubMedCentralPubMedCrossRef
7.
go back to reference Dubovsky J, Zabramski JM, Kurth J, Spetzler RF, Rich SS, Orr HT, et al. A gene responsible for cavernous malformations of the brain maps to chromosome 7q. Hum Mol Genet. 1995;4:453–8.PubMedCrossRef Dubovsky J, Zabramski JM, Kurth J, Spetzler RF, Rich SS, Orr HT, et al. A gene responsible for cavernous malformations of the brain maps to chromosome 7q. Hum Mol Genet. 1995;4:453–8.PubMedCrossRef
8.
go back to reference Ehtesham M, Kabos P, Yong WH, Schievink WI, Black KL, Yu JS. Development of an intracranial ependymoma at the site of a pre-existing cavernous malformation. Surg Neurol. 2003;60:80–82; discussion 83. Ehtesham M, Kabos P, Yong WH, Schievink WI, Black KL, Yu JS. Development of an intracranial ependymoma at the site of a pre-existing cavernous malformation. Surg Neurol. 2003;60:80–82; discussion 83.
9.
go back to reference Faurobert E, Albiges-Rizo C. Recent insights into cerebral cavernous malformations: a complex jigsaw puzzle under construction. FEBS J. 2010;277:1084–96.PubMedCentralPubMedCrossRef Faurobert E, Albiges-Rizo C. Recent insights into cerebral cavernous malformations: a complex jigsaw puzzle under construction. FEBS J. 2010;277:1084–96.PubMedCentralPubMedCrossRef
10.
go back to reference Fischer EG, Sotrel A, Welch K. Cerebral hemangioma with glial neoplasia (angioglioma?). Report of two cases. J Neurosurg. 1982;56:430–4.PubMedCrossRef Fischer EG, Sotrel A, Welch K. Cerebral hemangioma with glial neoplasia (angioglioma?). Report of two cases. J Neurosurg. 1982;56:430–4.PubMedCrossRef
11.
go back to reference Goodkin R, Zaias B, Michelsen WJ. Arteriovenous malformation and glioma: coexistent or sequential? Case report. J Neurosurg. 1990;72:798–805.PubMedCrossRef Goodkin R, Zaias B, Michelsen WJ. Arteriovenous malformation and glioma: coexistent or sequential? Case report. J Neurosurg. 1990;72:798–805.PubMedCrossRef
13.
go back to reference Kilic T, Pamir MN, Kullu S, Eren F, Ozek MM, Black PM. Expression of structural proteins and angiogenic factors in cerebrovascular anomalies. Neurosurgery. 2000;46:1179–1191; discussion 1191–72. Kilic T, Pamir MN, Kullu S, Eren F, Ozek MM, Black PM. Expression of structural proteins and angiogenic factors in cerebrovascular anomalies. Neurosurgery. 2000;46:1179–1191; discussion 1191–72.
14.
go back to reference Labauge P, Brunereau L, Levy C, Laberge S, Houtteville JP. The natural history of familial cerebral cavernomas: a retrospective MRI study of 40 patients. Neuroradiology. 2000;42:327–32.PubMedCrossRef Labauge P, Brunereau L, Levy C, Laberge S, Houtteville JP. The natural history of familial cerebral cavernomas: a retrospective MRI study of 40 patients. Neuroradiology. 2000;42:327–32.PubMedCrossRef
15.
go back to reference Laberge-le Couteulx S, Jung HH, Labauge P, Houtteville JP, Lescoat C, Cecillon M, et al. Truncating mutations in CCM1, encoding KRIT1, cause hereditary cavernous angiomas. Nat Genet. 1999;23:189–93.PubMedCrossRef Laberge-le Couteulx S, Jung HH, Labauge P, Houtteville JP, Lescoat C, Cecillon M, et al. Truncating mutations in CCM1, encoding KRIT1, cause hereditary cavernous angiomas. Nat Genet. 1999;23:189–93.PubMedCrossRef
16.
go back to reference Liquori CL, Berg MJ, Siegel AM, Huang E, Zawistowski JS, Stoffer T, et al. Mutations in a gene encoding a novel protein containing a phosphotyrosine-binding domain cause type 2 cerebral cavernous malformations. Am J Hum Genet. 2003;73:1459–64.PubMedCentralPubMedCrossRef Liquori CL, Berg MJ, Siegel AM, Huang E, Zawistowski JS, Stoffer T, et al. Mutations in a gene encoding a novel protein containing a phosphotyrosine-binding domain cause type 2 cerebral cavernous malformations. Am J Hum Genet. 2003;73:1459–64.PubMedCentralPubMedCrossRef
17.
go back to reference Maddaluno L, Rudini N, Cuttano R, Bravi L, Giampietro C, Corada M, et al. EndMT contributes to the onset and progression of cerebral cavernous malformations. Nature. 2013;498:492–6.PubMedCrossRef Maddaluno L, Rudini N, Cuttano R, Bravi L, Giampietro C, Corada M, et al. EndMT contributes to the onset and progression of cerebral cavernous malformations. Nature. 2013;498:492–6.PubMedCrossRef
18.
go back to reference Medici D, Shore EM, Lounev VY, Kaplan FS, Kalluri R, Olsen BR. Conversion of vascular endothelial cells into multipotent stem-like cells. Nat Med. 2010;16:1400–6.PubMedCentralPubMedCrossRef Medici D, Shore EM, Lounev VY, Kaplan FS, Kalluri R, Olsen BR. Conversion of vascular endothelial cells into multipotent stem-like cells. Nat Med. 2010;16:1400–6.PubMedCentralPubMedCrossRef
19.
go back to reference Mian MK, Nahed BV, Walcott BP, Ogilvy CS, Curry WT. Glioblastoma multiforme and cerebral cavernous malformations: intersection of pathophysiologic pathways. J Clin Neurosci. 2012;19:884–6.PubMedCrossRef Mian MK, Nahed BV, Walcott BP, Ogilvy CS, Curry WT. Glioblastoma multiforme and cerebral cavernous malformations: intersection of pathophysiologic pathways. J Clin Neurosci. 2012;19:884–6.PubMedCrossRef
20.
go back to reference Palma L, Mastronardi L, Celli P, d’Addetta R. Cavernous angioma associated with oligo-astrocytoma-like proliferation. Report of two cases and review of the literature with a reappraisal of the term “angioglioma”. Acta Neurochir (Wien). 1995;133:169–73. Palma L, Mastronardi L, Celli P, d’Addetta R. Cavernous angioma associated with oligo-astrocytoma-like proliferation. Report of two cases and review of the literature with a reappraisal of the term “angioglioma”. Acta Neurochir (Wien). 1995;133:169–73.
21.
go back to reference Riant F, Bergametti F, Ayrignac X, Boulday G, Tournier-Lasserve E. Recent insights into cerebral cavernous malformations: the molecular genetics of CCM. FEBS J. 2010;277:1070–5.PubMedCrossRef Riant F, Bergametti F, Ayrignac X, Boulday G, Tournier-Lasserve E. Recent insights into cerebral cavernous malformations: the molecular genetics of CCM. FEBS J. 2010;277:1070–5.PubMedCrossRef
22.
go back to reference Robinson JR, Awad IA, Little JR. Natural history of the cavernous angioma. J Neurosurg. 1991;75:709–14. Robinson JR, Awad IA, Little JR. Natural history of the cavernous angioma. J Neurosurg. 1991;75:709–14.
23.
go back to reference Sahoo T, Johnson EW, Thomas JW, Kuehl PM, Jones TL, Dokken CG, et al. Mutations in the gene encoding KRIT1, a Krev-1/rap1a binding protein, cause cerebral cavernous malformations (CCM1). Hum Mol Genet. 1999;8:2325–33.PubMedCrossRef Sahoo T, Johnson EW, Thomas JW, Kuehl PM, Jones TL, Dokken CG, et al. Mutations in the gene encoding KRIT1, a Krev-1/rap1a binding protein, cause cerebral cavernous malformations (CCM1). Hum Mol Genet. 1999;8:2325–33.PubMedCrossRef
25.
go back to reference Schreuder T, Te Lintelo M, Kubat B, Koehler P. Anaplastic oligo-astrocytoma occurring after resection of a cerebral cavernous malformation; malignant transformation? Case report and review on etiology. J Neurol. 2010;257:349–53.PubMedCrossRef Schreuder T, Te Lintelo M, Kubat B, Koehler P. Anaplastic oligo-astrocytoma occurring after resection of a cerebral cavernous malformation; malignant transformation? Case report and review on etiology. J Neurol. 2010;257:349–53.PubMedCrossRef
26.
go back to reference Wustehube J, Bartol A, Liebler SS, Brutsch R, Zhu Y, Felbor U, et al. Cerebral cavernous malformation protein CCM1 inhibits sprouting angiogenesis by activating DELTA-NOTCH signaling. Proc Natl Acad Sci U S A. 2010;107:12640–5.PubMedCentralPubMedCrossRef Wustehube J, Bartol A, Liebler SS, Brutsch R, Zhu Y, Felbor U, et al. Cerebral cavernous malformation protein CCM1 inhibits sprouting angiogenesis by activating DELTA-NOTCH signaling. Proc Natl Acad Sci U S A. 2010;107:12640–5.PubMedCentralPubMedCrossRef
Metadata
Title
Case Report: Glioblastoma Multiforme Complicating Familial Cavernous Malformations
Authors
D. M. Wilson, MD, PhD
B. Cohen, MD
K. Keshari, PhD
H. Vogel, MD
G. Steinberg, MD, PhD
W. Dillon, MD
Publication date
01-09-2014
Publisher
Springer Berlin Heidelberg
Published in
Clinical Neuroradiology / Issue 3/2014
Print ISSN: 1869-1439
Electronic ISSN: 1869-1447
DOI
https://doi.org/10.1007/s00062-013-0249-3

Other articles of this Issue 3/2014

Clinical Neuroradiology 3/2014 Go to the issue